ArticleJournal of family medicine and primary care2025
Antimicrobial susceptibility pattern of extended-spectrum β-lactamase producing gram-negative bacteria isolated from clinical samples: A cross-sectional hospital-based study.
Article in Journal of family medicine and primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The Gram-negative (GN) bacteria are known to cause a multitude of illnesses.The production of extended-spectrum beta-lactamases (ESBLs) is one of the contributing factors for drug resistance in bacteria. The present study was carried out to estimate the prevalence of ESBL-producing GN bacteria isolated from various clinical specimens in the population of Bihar, East India. Materials and Methods: This prospective cross-sectional study was conducted at Netaji Subhas Medical College and Hospital, a tertiary care hospital in Bihar, East India. The consecutive but non-repetitive clinical samples (urine, pus, sputum, and blood) obtained during the study period (July 2022 to March 2024) were included in the study. Samples from patients across all age groups and genders attending both outpatient and inpatient departments were included in the study. All cultures exhibiting no growth and urine and blood cultures exhibiting mixed growth were excluded from the study. ESBL-producing strains were suspected by phenotypic screening tests. Confirmation of ESBL-producing strains was done by the phenotypic test combined disc method. Results: Among 1123 organisms isolated in different specimens, 758 were GN, 324 Gram-positive bacteria, and 41 others. Conclusion:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.